Silgan Q1 adjusted EPS $0.78 versus $0.79 prior year; confirms FY2023 guidance $3.95-$4.15

SILGAN HOLDINGS INC

2023-Q1 EPS reported $0.65 revenue$1,418,281,000

Net sales $1.42B (-2% YoY); net income $72.0M ($0.65 diluted) vs $84.9M ($0.76) prior year.
Dispensing & Specialty Closures adjusted EBIT down $13.6M to $82.9M on resin cost lag; Metal Containers EBIT up $19.5M to $52.4M on volume growth.
Q2 2023 adjusted EPS guided $0.85-$0.95, down from record $1.09, due to higher interest, Russia comparables, and resin pass-through timing.
Full-year free cash flow expected ~$425M up from $368.2M; capex ~$250M; interest expense ~$155M.
Double-digit volume growth in fragrance/beauty dispensing; 3% organic volume growth in metal containers for pet food, soup, vegetables.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SILGAN HOLDINGS INC reported first quarter 2023 results: revenue $1.42 billion, net income $72.0 million, or $0.65 per diluted share, EPS $0.65 per diluted share. Guidance reaffirmed.

Period: first quarter 2023
Revenue: $1.42 billion
Net income: $72.0 million, or $0.65 per diluted share
EPS: $0.65 per diluted share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Silgan Holdings Inc. (NYSE: SLGN), a leading supplier of sustainable rigid packaging solutions for the world's essential consumer goods products, today reported first quarter 2023 net sales of $1.42 billion and net income of $72.0 million, or $0.65 per diluted share

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

SILGAN HOLDINGS INC filing history →

Source: SEC EDGAR

accession 0000849869-23-000074

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.